Eurola, A., Ristimäki, A., Mustonen, H., Nurmi, A., Hagström, J., Haglund, C., & Seppänen, H. (2021). Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationEurola, Annika, Ari Ristimäki, Harri Mustonen, Anna-Maria Nurmi, Jaana Hagström, Caj Haglund, and Hanna Seppänen. Impact of Histological Response After Neoadjuvant Therapy on Podocalyxin as a Prognostic Marker in Pancreatic Cancer. Nature Portfolio, 2021.
MLA (8th ed.) CitationEurola, Annika, et al. Impact of Histological Response After Neoadjuvant Therapy on Podocalyxin as a Prognostic Marker in Pancreatic Cancer. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.